Henry Watson

Doctor of Osteopathic Medicine,  Charité - Universitätsmedizin Berlin 

Location: Germany

Consulting Services

Biostatistics IT-Web-Mobile Technology Hospital-Pharmacy-Insurance Case Consulting Sales and Marketing

Areas Of Interest

Pressure, Maximal Expiratory Smokings, Non-Tobacco Products Sodium Cromoglycate Functional Aphonia Derivatives, Hydroxystilbene Phosphates, Inorganic Cremaster Muscles Glycines, N-substituted Blockade, Neuromuscular Regional Arterial Infusions Ultrapasteurization VAMP-1 Neocallimasticales Isoprenoid Phosphate Monosaccharides Adrenergic beta-2 Antagonists Carboxin Scanning Dysarthria A2B Receptor, Adenosine B.A.L. Enzootic Pneumonia of Pigs Cystatin Superfamily E2F Transcription Factor 2 Protein Cerebellar Incoordinations AY 4166 Arrestin 2 Benzoylcholine Phenomenon, Geological Hydatid Cysts, Pulmonary Cold-Stress Reactions Hydrochloride, Lofepramine Intralaminar Nuclear Group Selenate, Potassium Co-Immunoprecipitation Brucella Heart Valve Annulus Repair Enzyme-Labeled Antibody Technic Hemoglobin C Method, Teaching Age-Specific Death Rates o-Dihydroxybenzenes

Professional Narrative

Dr. Henry Watson was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Watson has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.

Employment

Executive Director, Harvard Med 2018
Executive Director, Amgen 2006

Education

Doctor of medicine, Weill Medical College 1998
Doctor of osteopathic medicine, Yale School of Medicine 2002

Referees

Publications

Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11. PMID: 32782413; PMCID: PMC7419031.

Tang Z, Kong N, Zhang X, Liu Y, Hu P, Mou S, Liljeström P, Shi J, Tan W, Kim JS, Cao Y, Langer R, Leong KW, Farokhzad OC, Tao W. A materials-science perspective on tackling COVID-19. Nat Rev Mater. 2020;5(11):847-860. doi: 10.1038/s41578-020-00247-y. Epub 2020 Oct 14. PMID: 33078077; PMCID: PMC7556605.

Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021;6(12):1078-1094. doi: 10.1038/s41578-021-00358-0. Epub 2021 Aug 10. PMID: 34394960; PMCID: PMC8353930.

Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021;6(12):1078-1094. doi: 10.1038/s41578-021-00358-0. Epub 2021 Aug 10. PMID: 34394960; PMCID: PMC8353930.

Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :

Languages

Language Proficiency :

Translation Services :

Serving Millions of physicians and biomedical scientists in Industry and academia.

Site
Services
Follow Us
Contact Us
  • support@scienceandminds.com

Copyright © 2025 Trialect Inc. All rights reserved. | v2023.06.17.02